IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 49.67

Change

-0.37 (-0.74)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-09 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-1.46 (-1.09%)

USD 35.08B
FHLC Fidelity® MSCI Health Care In..

-0.72 (-1.14%)

USD 2.50B
FXH First Trust Health Care AlphaD..

-0.71 (-0.71%)

USD 0.89B
XHE SPDR® S&P Health Care Equipme..

-0.27 (-0.33%)

USD 0.16B
IDNA iShares Genomics Immunology an..

-0.43 (-2.19%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

-0.52 (-0.53%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

-0.69 (-2.47%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.45 (-1.68%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

-1.19 (-2.16%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.27 (-1.54%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.23 % 0.00 %

-0.06 (-0.22%)

USD 0.08B
LCR Managed Portfolio Series 0.00 % 0.00 %

N/A

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.50% 90% A- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.50% 90% A- 75% C
Trailing 12 Months  
Capital Gain -6.53% 48% F 29% F
Dividend Return 0.58% 56% F 9% A-
Total Return -5.95% 52% F 25% F
Trailing 5 Years  
Capital Gain 30.74% 86% B+ 49% F
Dividend Return 5.33% 63% D 11% F
Total Return 36.07% 76% C+ 39% F
Average Annual (5 Year Horizon)  
Capital Gain 2.76% 62% D 47% F
Dividend Return 3.41% 62% D 41% F
Total Return 0.64% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.45% 43% F 52% F
Risk Adjusted Return 17.51% 57% F 36% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.